Back
Raffles Medical Group Vs. CytoMed Therapeutics Industry Stock Comparison
Buy
55
RAFLF
Raffles Medical Group
Last Price:
0.67
Seasonality Move:
0.99%
Buy
75
GDTC
CytoMed Therapeutics
Last Price:
2.49
Seasonality Move:
3.7%
Buy
55
Raffles Medical Group (RAFLF)
is a Buy
Is Raffles Medical Group a Buy, Sell or Hold?
- The current Raffles Medical Group [RAFLF] share price is $0.67. The Score for RAFLF is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- RAFLF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
CytoMed Therapeutics (GDTC)
is a Buy
Is CytoMed Therapeutics a Buy, Sell or Hold?
- The current CytoMed Therapeutics [GDTC] share price is $2.62. The Score for GDTC is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- GDTC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RAFLF Stock Price Chart
What is Raffles Medical Group's stock price today?
-
The Raffles Medical Group share price today is $0.67
The current trend is relatively stagnant and RAFLF is experiencing slight buying pressure.
GDTC Stock Price Chart
What is CytoMed Therapeutics's stock price today?
-
The CytoMed Therapeutics share price today is $2.62
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GDTC is experiencing slight buying pressure.
RAFLF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 74.22 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.67 - 0.67) | Buy |
| Bollinger Bands (100): | (0.65 - 0.73) | Sell |
GDTC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 60.98 | Buy |
| Chaikin Money Flow: | 820 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.91 - 2.59) | Buy |
| Bollinger Bands (100): | (1.55 - 2.23) | Buy |
RAFLF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.67 | Sell |
| 20-day SMA: | 0.67 | Sell |
| 50-day SMA: | 0.66 | Buy |
| 200-day SMA: | 0.72 | Sell |
| 8-day EMA: | 0.67 | Buy |
| 20-day EMA: | 0.67 | Buy |
| 50-day EMA: | 0.67 | Sell |
| 200-day EMA: | 0.73 | Sell |
GDTC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.47 | Buy |
| 20-day SMA: | 2.35 | Buy |
| 50-day SMA: | 1.88 | Buy |
| 200-day SMA: | 2.11 | Buy |
| 8-day EMA: | 2.47 | Buy |
| 20-day EMA: | 2.33 | Buy |
| 50-day EMA: | 2.07 | Buy |
| 200-day EMA: | 2.22 | Buy |
Raffles Medical Group Earnings Growth & RAFLF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CytoMed Therapeutics Earnings Growth & GDTC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.02 per share.
Raffles Medical Group Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CytoMed Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||